Recently, the search frequency for Genexine, known as a specialized company in biopharmaceutical development, has surged.
As of 11:30 AM on the 24th, Genexine's stock price rose 1.77% from the previous day to 97,800 KRW, with a trading volume of 150,133 shares, which is about 9.0% of the 5-day average trading volume. Foreign investors are tentatively reported to have net purchased 3,458 shares today.
On February 18th, Genexine became a market issue with the headline "Soars on news of immune-oncology technology export."
※ Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
